Navamedic ASA, 21 November 2019: Toril Marie Ås resigns from her position as CFO in Navamedic ASA ("the Company" or "Navamedic") with effect from 9 December 2019. She will continue to work for the Company for a limited period after this date to assist the new CFO with relevant transition tasks.
“Navamedic and I would like to thank Toril for her great service to the company, and especially for her effort relating to the completed demerger and separate listing of Observe Medical. I wish her all the best for the future,” says Kathrine Gamborg Andreassen, CEO of Navamedic.
For further information, please contact:
Kathrine Gamborg Andreassen, CEO, Navamedic
Mobile: +47 951 78 680
About Navamedic ASA:
Navamedic ASA is a full-service provider of high-quality healthcare products to hospitals and pharmacies. Navamedic meets the specific medical needs of patients and consumers by leveraging its highly scalable market access platform, leading category competence and local knowledge. Navamedic is present in all the Nordic countries, the Baltics and Benelux, with sales representation in the UK and Greece. Navamedic is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (ticker: NAVA). For more information, please visit www.navamedic.com.